NCIRE - The Veterans Health Research Institute Home  |  Sitemap  |  Intranet  |  UltiPro   Visit our Facebook page  Visit our Twitter page

Give Now
About NCIRE Participate in Research Support Our Mission Careers at NCIRE Contact Us
Veterans Health
Research at NCIRE

NCIRE-The Veterans Health Research Institute is the leading private nonprofit institute devoted to Veterans health research in the United States. Our mission is to advance Veterans health through research.

We support the work of some of the nation's foremost physicians and scientists at the San Francisco Veterans Affairs Medical Center, the premier biomedical research facility in the VA system. All have faculty appointments at the University of California, San Francisco, which has its own proud traditions of research and patient care. We also partner with the U.S. Department of Defense to support health research on behalf of our men and women in the Armed Forces.

Those who have served in uniform have given their best for their country. In return, we believe that they deserve nothing less than the best health care research we can provide.

Contact Us
Email NCIRE
Give Now
S. Marlene Grenon, MD, CM

Vascular Surgeon and Associate Professor of Surgery, UCSF
Email: marlene.grenon@ucsf.edu

Vascular Rehabilitation: Improving Lifestyle Factors for Patients With Cardiovascular Diseases.

My current research program focuses on lifestyle modifications and vascular rehabilitation for patients with vascular disease. It is well known that lifestyle issues including nutrition, physical activity, and emotional stress have a high impact on disease development and rehabilitation in patients with heart disease. The evidence for how nutrition, physical activity, and emotional stress affect patients with other vascular diseases such as peripheral artery disease (PAD) is less clear. In my research program, we are conducting different clinical studies on how these factors impact PAD, with the aim to improve the quality of life and outcomes of patients with vascular diseases.

OMEGA-PAD I Trial (completed): In this double-blind, randomized control trial, we investigated the hypothesis that short-term (1 month), high-dose n-3 PUFA supplementation improves endothelial function and inflammation in patients with stable claudication. 

OMEGA-PAD II Trial (enrolling): In this double-blind, randomized control trial, we are investigating the hypothesis that high-dose n-3 polyunsaturated fatty acids (PUFA) oral supplementation improves systemic inflammation, vascular function, and symptomatic status of patients with PAD. We are also exploring novel mechanistic pathways by which n-3 PUFA affect PAD, evaluating the role of specialized lipid mediators involved in the resolution of inflammation.

OMEGA-PVI Trial (enrolling): In this double-blind, randomized control trial, we are addressing the hypothesis that high-dose n-3 polyunsaturated fatty acids (PUFA) oral supplementation will improve will improve systemic inflammation and patency of peripheral vascular intervention (PVI).

 

To see Dr. Grenon on PubMed, click here.